BDX (BD) נכסי החברה

This daily price chart for Becton Dickinson & Co (BDX), currently valued at 38565.57, reflects the impact of implementing smart pumps and molecular diagnostics. High-yield M&A deals and equipment for chronic pathology therapy are driving the growth in market capitalization. Basic consumables with steady demand provide a consistent cash flow. Such a model transforms the production of simple instruments into a reliable cash cow with immense momentum.

The efficiency of Becton Dickinson & Co (BDX) depends directly on clinic equipment levels and the stability of medical technology supplies. Total assets, calculated inversely via ROA, measure the aggregate volume of resources deployed to generate profit. Growth in this metric signals an expansion of production capacity; however, excessive debt leverage increases financial risks. By analyzing total asset trends (via ROA) on GURU.Markets, an investor assesses the stability of the company's asset base.